Dream Exchange Research Chief Presents Market Structure Findings at Global Universities
Event summary
- Dream Exchange Research Director Dr. Ioannis Floros presented two papers at University of Cyprus (Jan 22) and Loyola University Chicago (Feb 6)
- First paper examined why some PIPE deals occur above market price
- Second paper analyzed ownership structures in pharmaceutical industry collaborations
- Floros serves as Hans G. Storr Associate Professor in Finance at University of Wisconsin-Milwaukee
- Dream Exchange preparing to re-file Form 1 application with SEC for national exchange registration
The big picture
Dream Exchange's research director is actively bridging academic theory and market practice through university presentations, while the company prepares to re-file its national exchange application. This dual focus on intellectual capital and regulatory approval positions Dream Exchange as a potential innovator in small-cap market access. The pharmaceutical industry research suggests potential applications for biotech companies seeking public market access through Dream Exchange's planned platform.
What we're watching
- Research Impact
- How Dream Exchange will apply these academic findings to its exchange operations
- Regulatory Timeline
- The pace at which Dream Exchange can complete its Form 1 re-filing process
- Market Differentiation
- Whether Dream Exchange's research focus will create competitive advantage in small-cap exchange space
Related topics
